From: medicalxpress.com A team of researchers from Weill Cornell Medicine, the British Columbia Cancer Research Centre and Memorial Sloan Kettering Cancer Center, working with a group from the IMAXT Consortium, has used single-cell sequencing to reveal breast and ovarian cancer-related mutational processes. In their paper published in the journal Nature, the group describes how they conducted single-cell genome sequencing on …